- The RING-E2 interaction is a central molecular event in the function of RING E3 ubiquitin ligases. RING domains interact with ubiquitin-conjugating E2 enzymes and help position an activated ubiquitin molecule for transfer to a target protein. This interaction provides an important connection between the structural properties of the RING finger domain and the enzymatic activity of RING E3 ligases. Understanding how RING and E2 proteins interact helps explain how ubiquitination is controlled at the molecular level.
- The ubiquitination process involves the sequential action of E1 ubiquitin-activating enzymes, E2 ubiquitin-conjugating enzymes, and E3 ubiquitin ligases. E1 first activates ubiquitin in an ATP-dependent reaction and transfers the activated ubiquitin to an E2 enzyme. The E2 then carries the activated ubiquitin through its catalytic cysteine. A RING E3 ligase subsequently interacts with the E2-ubiquitin complex and its substrate, helping facilitate transfer of ubiquitin to the target protein.
- The RING domain provides the principal interaction surface for many RING-E2 complexes. Its compact zinc-coordinating structure creates a molecular interface capable of recognizing particular surfaces on an E2 enzyme. Although RING domains share characteristic structural features, individual RING proteins can have different interaction preferences. The amino acid composition and three-dimensional arrangement of the RING domain contribute to the strength and specificity of E2 binding.
- The E2 enzyme is an essential component of this interaction because it carries the activated ubiquitin. E2 proteins contain a conserved catalytic domain known as the UBC domain, which contains the catalytic cysteine responsible for receiving ubiquitin from E1. When an E2 enzyme binds a RING domain, the RING-E2 complex brings the ubiquitin-loaded E2 into a position that supports efficient ubiquitin transfer.
- An important feature of RING-mediated ubiquitination is that the RING domain generally does not form a stable covalent ubiquitin intermediate. Instead, the RING protein acts primarily as a molecular scaffold or activator that promotes ubiquitin transfer directly from the E2 enzyme to the substrate. This distinguishes many RING E3 ligases from HECT E3 ligases and RBR E3 ligases, which use different catalytic mechanisms involving additional ubiquitin-transfer steps.
- The structure of the RING-E2 complex provides important information about how ubiquitination occurs. Structural studies have shown that the RING domain interacts with a surface of the E2 enzyme away from its catalytic center while helping orient the E2-bound ubiquitin. This positioning can promote a productive configuration in which the activated ubiquitin is appropriately aligned for transfer to a substrate.
- The E2~ubiquitin complex is therefore a critical intermediate in RING E3 ligase activity. The tilde notation is commonly used to indicate the activated, thioester-linked ubiquitin attached to the catalytic cysteine of E2. The RING domain interacts with this complex and can influence the conformation of the E2-bound ubiquitin. These structural changes can affect how efficiently ubiquitin is transferred.
- Different RING E3 ligases can interact with different E2 enzymes. Some RING proteins show relatively broad E2 compatibility, whereas others display greater selectivity. E2 choice can influence the efficiency of ubiquitination and, in some systems, the type of ubiquitin modification that is produced. Consequently, identifying the E2 partners of a RING protein is an important step in understanding its biological function.
- The interaction between a particular RING protein and E2 can also influence ubiquitin chain formation. Depending on the RING-E2 combination, substrate, and cellular environment, ubiquitination may result in monoubiquitination, multi-monoubiquitination, or formation of polyubiquitin chains. Different chain architectures can generate different biological signals, including signals associated with protein degradation, DNA repair, intracellular trafficking, or signaling.
- The RING domain and E2 enzyme do not operate independently of the substrate. Productive ubiquitination generally requires coordination between the RING-E2 complex and the substrate-recognition region of the E3 ligase. In some RING proteins, the RING domain and substrate-binding region are contained within the same protein. In other systems, adaptor proteins or additional complex components help connect the RING-E2 machinery with the appropriate substrate.
- The distance and orientation between the RING domain, E2 enzyme, and substrate can therefore be important. Productive ubiquitin transfer requires the catalytic region of the E2 enzyme and the target lysine or other acceptor site on the substrate to be positioned appropriately. Structural organization within the complete E3 complex can influence whether this geometry is achieved efficiently.
- RING domain mutations can affect E2 binding and ubiquitin ligase activity. Mutations that disrupt conserved zinc-coordinating residues may destabilize the RING structure and indirectly interfere with E2 interaction. Other substitutions may occur directly at or near the E2-binding interface and alter the strength or geometry of the interaction. Functional experiments can help distinguish mutations that affect folding from those that specifically alter E2 recognition.
- The interaction can also be influenced by post-translational modifications. Phosphorylation, ubiquitination, and other modifications of the RING protein or its associated components may alter protein conformation, localization, complex formation, or E2 recruitment. These regulatory mechanisms allow cells to adjust RING E3 ligase activity according to cellular signals and environmental conditions.
- Some RING E3 ligases function as multisubunit complexes, making the RING-E2 interaction part of a larger molecular assembly. In these systems, one protein may contain the RING domain while another component provides substrate-recognition activity. Additional proteins can stabilize the complex or regulate its activity. Studying the complete complex is therefore often necessary to understand how the RING-E2 interaction operates inside the cell.
- RING-E2 interactions are also important for understanding substrate specificity. The RING domain may determine which E2 enzyme participates in ubiquitination, while other regions of the E3 complex determine which substrate is recognized. The combination of E2 selection and substrate recognition can therefore contribute to the specificity of an individual ubiquitination pathway.
- Experimental approaches used to investigate RING-E2 interactions include protein-protein interaction assays, co-immunoprecipitation, pull-down experiments, mutational analysis, ubiquitination assays, biochemical reconstitution, and structural techniques. These methods can reveal whether two proteins interact, identify important residues, measure ubiquitination activity, and determine the molecular architecture of the complex.
- Structural biology has provided particularly valuable information about RING-E2 complexes. X-ray crystallography, nuclear magnetic resonance spectroscopy, cryo-electron microscopy, and computational structural modeling can reveal how conserved residues contribute to protein-protein interactions. Comparing structures from different RING-E2 pairs can also help explain why some E3 ligases interact preferentially with particular E2 enzymes.
- Computational methods can complement experimental studies by predicting protein-protein interactions and identifying conserved residues at potential binding interfaces. Sequence alignment can reveal residues conserved among related RING proteins, while structural prediction can help identify potential interaction surfaces. These predictions generally require experimental validation because sequence similarity alone does not establish a functional RING-E2 interaction.
- The RING-E2 interaction is also relevant to drug discovery and therapeutic research. Compounds that interfere with an E3-E2 interaction could potentially alter the activity of a specific ubiquitination pathway. Conversely, compounds that stabilize or enhance productive interactions may increase ubiquitination of selected substrates. Designing selective modulators is challenging because protein-protein interfaces can be relatively broad and because RING E3 ligases participate in complex cellular networks.
- Understanding RING-E2 interactions also helps explain why alterations in ubiquitination can have effects on cancer, DNA repair, immune signaling, and protein homeostasis. If an E3 ligase cannot efficiently recruit its appropriate E2 enzyme, substrate ubiquitination may be reduced or altered. Conversely, excessive or inappropriate E3 activity can change the abundance or activity of important regulatory proteins. The biological consequences depend on the particular RING-E2 pair and the cellular pathway involved.
- An important distinction is that not every RING E3 ligase uses exactly the same mechanism or produces the same ubiquitin signal. Structural differences between RING domains, E2 enzymes, substrates, and associated proteins create substantial functional diversity. Consequently, conclusions about one RING-E2 pair should not automatically be generalized to all RING-containing E3 ligases.
- Overall, the RING-E2 interaction provides the molecular link between the RING domain structure and ubiquitin transfer. The RING domain recognizes and organizes the ubiquitin-loaded E2 enzyme, while the broader E3 complex brings the appropriate substrate into the reaction. The resulting coordination allows RING E3 ligases to regulate protein ubiquitination with considerable specificity.
